0.06 - 0.06
0.06 - 0.24
8.7K / 3.59M (Avg.)
-1.55 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2651911.03%
10Y revenue/share CAGR under 50% of SMR.AX's 32265540.15%. Michael Burry would suspect a lasting competitive disadvantage.
No Data
No Data available this quarter, please select a different quarter.
18.52%
3Y revenue/share CAGR under 50% of SMR.AX's 73.94%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
195.55%
OCF/share CAGR of 195.55% while SMR.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
307.27%
OCF/share CAGR of 307.27% while SMR.AX is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-2.96%
Negative 3Y OCF/share CAGR while SMR.AX stands at 102.09%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
156.11%
Below 50% of SMR.AX's 10968.62%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
161.32%
Net income/share CAGR of 161.32% while SMR.AX is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
742.17%
3Y net income/share CAGR above 1.5x SMR.AX's 25.44%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
69.11%
Equity/share CAGR of 69.11% while SMR.AX is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
-146.29%
Negative 3Y equity/share growth while SMR.AX is at 354.34%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.